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EFFECT OF SHOCK ABSORBING INSOLES ON BIOMECHANICAL AND
CLINICAL ASPECTS OF KNEE OSTEOARTHRITIS
A. De Vincenzo1, A. Apps1, T. Cooney1, M. MacKenzie1, K. Turpin1,
R. Chang2, M.A. Hunt1. 1Univ. of British Columbia, Vancouver, BC, Canada;
2Univ. of the Fraser Valley, Abbotsford, BC, Canada
Purpose: It is widely recognized that excessive joint loading contributes
to the development of articular cartilage degeneration. Thus, treatment
for knee OA should focus on decreasing knee load to improve symptoms
and reduce the risk of disease progression. Several therapeutic methods
have been examined that look at ways to decrease knee load and/or
improve pain and function. Shock absorbing insoles are common
therapeutic devices used to improve pain, but their effects on joint
load and pain in a knee OA population are unknown. Therefore, the aim
of this study was to examine the immediate and short-term (1 month)
changes in knee joint loading and pain following the insertion of shock
absorbing insoles into the shoes of patients with knee OA.
Methods: Sixteen community-dwelling individuals (6M, 10F, age:
66.9±12.5 years, BMI: 27.7±7.3 kg/m2), with radiographically-conﬁrmed
medial compartment knee OA underwent testing on two separate
occasions (baseline and follow-up). On both testing sessions,
measurements of physical function and walking patterns were
conducted. Participants also completed the Western Ontario and
McMaster Universities Index (WOMAC) to assess self-reported pain.
Furthermore, self-reported knee pain during walking was determined
using a numerical rating scale (NRS) of 0–10 (0=no pain, 10=most pain
ever felt in knee). Objective physical function was assessed as the time to
ascend 12 stairs. All participants underwent 3-dimensional gait analysis
at a self-selected walking speed in their normal walking shoes under two
different randomly-presented conditions: 1) shoes only, 2) insertion of
3/4 length gel insoles with no medial or lateral arches. Reﬂective makers
were placed on the participants’ skin over speciﬁc lower limb anatomical
landmarks, and their positions were tracked using 8 high-speed, digital
cameras (Motion Analysis Corp.) sampling at 120Hz. Ground reaction
force data were sampled at 1200Hz using 2 force platforms (AMTI)
placed in the centre of an 8m walkway. A biaxial accelerometer was
placed on the tibial tuberosity to measure vertical acceleration of the
lower leg upon impact. A total of 5 walking trials with and without the
insoles were completed at both sessions. Participants were sent home
with the insoles and completed a diary to indicate the amount of wear
time over the next month. The primary outcome measures were: the
peak external knee adduction moment (KAM), the KAM impulse (area
under the KAM curve), and peak tibial acceleration. Secondary outcomes
were: walking pain (quantiﬁed using the NRS), WOMAC pain and total
scores, and timed stair climb. Within- and between-session differences in
the primary outcomes were evaluated using a 2-factor repeated measures
analysis of variance to assess, while between-session differences in the
secondary outcomes were evaluated using paired t-tests.
Results: Participants wore their insoles an average of 213.4±98.1 hours
over the one month trial. Effect sizes for the knee joint loading
measures were small (d=0.13–0.20), and no signiﬁcant within- or
between-session knee joint loading differences were observed for any
biomechanical variable (p > 0.05). Conversely, signiﬁcant improvements
were found for walking pain (2.5±1.9 vs. 4.2±2.7; p = 0.04), WOMAC
pain subscale (4.4±3.1 vs. 6.4±2.9; p = 0.02), and the total WOMAC
score (25.3±13.5 vs. 30.7±14.8; p = 0.04). Finally, the time to ascend
12 stairs was signiﬁcantly (p = 0.01) shorter at the follow-up assessment
(6.1±2.7 seconds) compared to baseline (6.5±3.1 seconds).
Conclusions: Although there were no improvements in knee joint
loading, pain and function were found to be signiﬁcantly improved with
the use of the shock absorbing insoles for one month. Therefore, although
the shock absorbing insoles can improve clinical symptoms, their effect
on disease progression is less clear.
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CLINICAL EFFICACY AND PARAMETERS OF TENS AFTER TOTAL KNEE
ARTHROPLASTY: A SYSTEMATIC REVIEW
D. Beckwe´e1, E. Swinnen1, Y. Vermet1, I. Bautmans2, P. Vaes1, P. Lievens1.
1Vrije Univ.it Brussel, Brussels, Belgium; 2Univ. Hosp. Brussels, Brussels,
Belgium
Purpose: Knee arthroplasty (KA) is a painful procedure and pain may
be a barrier for an efﬁcient rehabilitation. Therefore an effective pain
management is believed to be necessary to achieve good rehabilitation
outcomes. Transcutaneous Electrical Nerve Stimulation (TENS) is a non-
pharmacological and non-invasive treatment that may inﬂuence the pain
after KA. TENS seems to be an effective therapy after surgical procedures
such as cardial surgery, thoracotomy and inguinal herniorrhaphy. It is
believed that maximal analgesic effect would be achieved using a high
pulse intensity of the TENS current.
The aims of this review were:
1. To evaluate the clinical efﬁcacy of TENS in the treatment of
postoperative KA pain, range of motion (ROM) and loss of function.
2. To relate possible effects to the TENS parameters used.
Methods: A systematic literature search was conducted by using
Pubmed, Web of knowledge and Pedro (search terms: (post-surgery
knee arthroplasty OR after operation knee arthroplasty OR knee
replacement OR knee arthroplasty OR knee prosthesis) AND (TENS OR
transcutaneous electrical nerve stimulation OR percutaneous electrical
nerve stimulation) AND (pain OR function OR range of motion)). A hand
search of reference lists of included papers was conducted to get more
potential references. Papers were included if pain, ROM or function were
used as an outcome measure for the effect of TENS after KA. The quality
of each included study was assessed by two independent evaluators on a
total score of 100 with a focus on comparability of groups, interventions
and effect assessment and data presentation.
Results: Four studies met the inclusion criteria. The methodological
assessment of all studies was found to be low, i.e. between 20/100 and
35/100. Pain was an outcome measure in all 4 studies. Two studies used
ROM and no studies used function as an outcome measure. No signiﬁcant
effect on pain or ROM has been found. The parameters of the TENS
currents differed between the included studies. In one study the pulse
intensity was controlled by the patient and was not registered. In another
study the intensity was set at a strong but non-painful stimulation. In
two other studies, the pulse intensity was set at 14mA (i.e. no sensation)
and 40mA (i.e. maximum comfortable sensory stimulation below the
level of visible muscle contraction).
Conclusions: No scientiﬁc evidence was found in the literature for the
effectiveness of TENS on pain, ROM or function following KA.
However, the available studies showed numerous methodological and
intrinsic ﬂaws (heterogeneity of the current parameters). Moreover, high
pulse intensity TENS (i.e. comfortable but near pain threshold TENS)
needs more attention in future studies.
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EFFICACY OF RADIOFREQUENCY HYPERTHERMIA IN SYMPTOMS
OF KNEE OSTEOARTHRITIS
K. Takahashi1, H. Kurosaki2, S. Hashimoto3, K. Takenouchi1, T. Kamada4,
H. Nakamura1. 1Dept. of Rheumatology, Nippon Med. Sch., Tokyo, Japan;
2Cancro Clinic, Tokyo, Japan; 3Hashimoto Clinic, Tokyo, Japan; 4Hara
Orthopaedic Hosp., Tokyo, Japan
Purpose: The clinical evidence of the efﬁcacy of hyperthermia on
osteoarthritis (OA) has not yet been clearly established. In addition,
the application of a modality that can control the temperature inside the
joints has not been reported. Radiofrequency refers to electromagnetic
waves having a frequency of from 3 to 30 MHz and these can heat the
body from inside by utilizing the thermogenesis caused by the dielectric
loss. The purpose of this study was to examine whether radiofrequency
hyperthermia could safely increase the temperature inside joints by
exposing knees percutaneously. In addition, we also attempted to clarify
the therapeutic potential of percutaneous radiofrequency hyperthermia
in patients with OA knee.
Methods: Hermotron-RF8 (Yamamoto Vinita, Co, Ltd, Osaka, Japan)
was used for hyperthermia. Temperature changes inside a knee joint
without OA were measured during the exposure to radiofrequency.
Radiofrequency hyperthermia was performed on OA knees by the
exposure of 8 MHz and 200 W for 20 minutes, 3 times at a one-
week interval. The subjects comprised 12 joints of 11 patients (1 males
and 10 females), aged 62–81 years (mean: 70.4±6.4 years) who were
diagnosed as having knee OA based on the American College of
Rheumatology (ACR) criteria. According to Kellgren-Lawrence grade,
grades were II: joint 6, III: joint 5, VI: joint 1, and an early to advanced
stage of OA was prevalent. The clinical outcome was evaluated using the
Lequesne Index (LI) and the Japan Orthopaedic Association (JOA) scale.
Results: Radiofrequency hyperthermia of 8 MHz and 200 W for
20 minutes increased the temperature inside the joint from 34.4 to
39.4°C. The LI showed a progressive reduction in mean score points
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during 2 weeks of treatment and at the ﬁnal examination 1 week
after the last hyperthermia relative to the baseline value of 9.55 points.
The mean absolute score reductions reaches 3.55 points at the ﬁnal
examination. JOA scale improved signiﬁcantly over time, reaching 86.25
points at the ﬁnal examination from the baseline average score of 67.5
points. Five joints (62%) reached 95 points or more and almost all of
the symptoms were eradicated. During the study, no side effects such as
an exacerbation of swelling, burning, or paraesthesia were observed to
result from exposure to the radiofrequency.
Conclusions: The primary goals of contemporary therapy for OA are to
reduce pain, improve joint function and improve quality of life because
there is no structure modifying therapy for OA that has gained consensus
at this point. In animal studies, the expression of proteoglycan and type
II collagen in the articular cartilage signiﬁcantly increases at a level
in which the temperature inside the joint increased to approximately
40°C. Moreover, heat shock protein 70 (HSP 70) was accumulated in
chondrocyte when the articular cartilage was heated to 40°C in vivo. HSP
70 provides effects to inhibit apoptosis of chondrocytes and to accelerate
the proteoglycan metabolism. In this study, radiofrequency hyperthermia
safely increases the temperature inside the knee joint. Radiofrequency
on OA knee provides a remarkable pain relief effect and can improve the
patients’ daily life. In the future, clinical studies should be performed
with a protocol containing more cases along with appropriate control
groups.
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HIGH-MOLECULAR-WEIGHT HYALURONAN (EUFLEXXA®) FOR
THE TREATMENT OF CHRONIC SHOULDER PAIN ASSOCIATED WITH
GLENOHUMERAL ARTHRITIS
A.J. Weil. Non-Surgical Orthopaedics, P.C., Atlanta, GA, USA
Purpose: There is insufﬁcient evidence to determine whether intra-
articular (IA) injections may be effective for treatment of glenohumeral
osteoarthritis (OA). Euﬂexxa, a high molecular weight hyaluronan (1%
sodium hyaluronate; HMWHA), has been shown to be a safe and effective
treatment for patients with knee OA. There is also support for the use of
HA injection for the treatment of chronic shoulder pain associated with
OA or rotator cuff damage. This study was conducted to evaluate the
safety and efﬁcacy of HMW HA for the treatment of chronic shoulder
pain associated with osteoarthritis (OA).
Methods: Subjects with glenohumoral OA and chronic pain (n =27)
received 3 weekly injections of HMW HA and were assessed for changes
in pain (100mm visual analog scale [VAS]), range of motion, and the
subject’s and physician’s global assessment over 26 weeks. Subjects
were also assessed for pain, stiffness, and physical functioning using the
Western Ontario and McMaster Universities Arthritis Index (WOMAC).
Finally, responses were evaluated using modiﬁed Outcome Measures in
Rheumatoid Arthritis Clinical Trials (OMERACT) – Osteoarthritis Research
Society International (OARSI) Proposition D Criteria. Safety was assessed
by recording adverse events (AEs).
Results: HMW HA signiﬁcantly improved pain (VAS, WOMAC), range
of motion, stiffness, and physical functioning scores. 77.8% of subjects
were rated as having an OMERACT-OARSI Proposition D high response.
There were no serious AEs and no AEs were considered to be related to
treatment.
Conclusions: HMW HA should be considered as a treatment option
for patients with symptomatic shoulder OA after traditional nonsurgical
treatment options have failed.
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PATIENTS WITH KNEE OSTEOARTHRITIS DEMONSTRATE IMPROVED
GAIT AND CLINICAL SYMPTOMS FOLLOWING A NON-INVASIVE
BIOMECHANICAL THERAPY
R. Lador1, G. Segal2, Y. Kosashvili3, M. Drexler1, O. Chechik1, A. Haim1,
M. Salai1, R. Debi4, A. Elbaz2. 1Sourasky Med. Ctr., Tel-Aviv, Israel;
2AposTherapy Res. Group, Herzliya, Israel; 3Assaf Harofeh Med. Ctr., Zeriﬁn,
Israel; 4Barzilay Med. Ctr., Ashkelon, Israel
Purpose: Biomechanical interventions for the management of knee
osteoarthritis (OA) are emerging. AposTherapy is one type of
biomechanical therapy that was shown to reduce knee adduction
moment and improve gait patterns and clinical symptoms. The purpose
of the current study was to further investigate the changes in gait
patterns following AposTherapy and to deﬁne the possible clinical
beneﬁts of the therapy for patients with knee OA.
Methods: 412 patients with knee OA were evaluated using a
computerized gait test as well as with the Western Ontario and
McMaster Osteoarthritis Index (WOMAC) and SF-36 Health Survey self-
evaluation questionnaires. Following these measurements, the Apos
system was individually calibrated to each patient according to his or
her gait patterns and clinical evaluation. Patients then received exercise
guidelines and underwent AposTherapy. A second evaluation of gait and
clinical symptoms was conducted after three months of therapy.
Results: After three months of therapy, a signiﬁcant improvement was
found in all gait parameters (all p< 0.01), as well as in the level of pain,
function and quality of life (all p < 0.01). High correlations were found
between the improvement in gait parameters and the improvement in
self-evaluation questionnaires.
Conclusions: AposTherapy led to a signiﬁcant reduction in pain and
improvement in function, quality of life and gait patterns. These ﬁnding
support previous ﬁndings and deepens the understanding of this new
non-invasive biomechanical therapy in patients with knee OA.
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EFFECTS OF LOW POWER LASER THERAPY ON ARTICULAR CARTILAGE
BIOMECHANICS IN AN EXPERIMENTAL MODEL OF OSTEOARTHRITIS
Z.S. Rezaeian1, G. Torkaman1, A. Esteki2, A. Sabbaghian3, R. Ravanbod4.
1Tarbiat Modares Univ., Tehran, Iran, Islamic Republic of ; 2Shahid Beheshti
Univ., Tehran, Iran, Islamic Republic of ; 3Akhtar Hosp., Tehran, Iran, Islamic
Republic of ; 4Hemophilia Comprehensive Treatment Ctr., Tehran, Iran,
Islamic Republic of
Purpose: Articular cartilage is a specialized connective tissue covering
articular surface in synovial joints. According to the position of cartilage
in these joints, any motion results in different compressive and shear
loading on cartilage; cartilage healing is too slow. In abnormal situations,
cartilage wear and tear can precede regeneration resulting in cartilage
degeneration phenomenon known as oseteoarthritis (OA).
Variety of researches is running to identify OA characteristics and
compare the quality and duration of the effects of therapeutic strategies.
On the other hand, experimental models using laboratory animales
are especially There are different animal models to study OA however
anterior cruciate ligament transaction (ACLT) is more common.
Low Power Laser Therapy (LPLT) is one of the common physical
modalities to relief pain. OA results in structural and functional changes
in cartilage. The question is wheater LPLT can affect cartilage function
or not? Present study focused on the short-term effects of LPLT on the
bimoechanical properties of articular cartilage as an index of cartilage
function in rabbit ACLT model.
Methods: Total of 15 male white skeletally mature Dutch rabbits
weighting 1.5 to 2 kg devided into 3 groups (85 Control, 85 Surgery
and Laser). The anterior cruciate ligament (ACL) was cut in the left knee
of rabbits in 85 Surgery and Laser groups. The rabbits were housed
seperatedly in cages where they can move easily and have free access to
food and water. 85 days (3 months) following the surgery theses rabbit
were sacriﬁced. 85 Control group underwent no intervention during the
same period.
LPLT started at the 62th day after surgery for 10 sessions, 3 days a week
using Ga-Al-As pulse 810nm Laser (Physiolaser, RJ Laser, Germany).
For biomechanical test, tibia and femur seperated and prepared for
thickness measurement and stress-relaxation test by Zwick Universal
Testing Machine; Zwick/Roell GmbH & Co., Ulm, Germany.
Kruskal Wallis test used to detect any difference between groups with
alpha = 0.05 and Beta = 0.95. To determine which two groups were
signiﬁcantly different the Mann-Withney test was used.
Results: Cartilage thickness of tibia and femur was not different while
comparing groups (Table 1). On the other hand, signiﬁcant differences
between tibial cartilages were observed in different groups as shown
in Figure 1. Maximal force in 85 control group was signiﬁcantly less
than 85 surgery and laser groups (P = 0.014 and P=0.043 respectively).
Same differences were detected in Young modulus (P = 0.014, P = 0.043
respectively).
The ACL is one of the four major knee ligaments. The injured ACL cannot
control knee movement especially tibial anterior glide therefore, knee
bones rub against each other in an abnormal way. The induced abnormal
sliding can damage the cartilage, menisci and even other ligaments
around the knee and eventually results in OA.
